The global Dehydroquercetin (DHQ) market is experiencing robust growth, driven by increasing consumer awareness of its potent antioxidant and anti-inflammatory properties. The market, valued at approximately $150 million in 2025, is projected to exhibit a Compound Annual Growth Rate (CAGR) of 8% from 2025 to 2033, reaching an estimated $275 million by 2033. This expansion is fueled by several key factors. The rising prevalence of chronic diseases, such as cardiovascular disease and cancer, is boosting demand for natural health supplements with proven efficacy, with DHQ's established therapeutic benefits positioning it favorably. Furthermore, the growing popularity of functional foods and beverages incorporating DHQ as a key ingredient contributes significantly to market growth. This trend is especially prevalent in North America and Europe, which are currently the leading regional markets. However, challenges remain. The relatively high cost of DHQ extraction and purification, coupled with the need for rigorous quality control measures, pose constraints on market penetration.